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Abstract
This research study examines the synthesis 
of tyrosine containing peptides based on 
the protein paxillin. Paxillin is a proposed 
substrate of the Focal Adhesion Kinase 
(FAK) protein tyrosine kinase. FAK is 
overexpressed in tumor cells; therefore, its 
abnormal function is associated with several 
cancer types. The peptides designed here 
are based on the substrate sequence FAK 
preferably binds to and phosphorylates. 
Solid Phase Peptide Synthesis (SPPS) 
provided substrate compounds which were 
then tested via biological assays with FAK. 
The synthesis of large peptides provides an 
accurate method to determine kinase amino 
acid phosphorylation preference to confirm 
paxillin as a FAK substrate.
Introduction
Cancer is the second leading cause 
of death in the United States. About 
570,280 Americans are expected to 
die of cancer in 2005, more than 
1,500 people per day.1 There are 
numerous factors which contribute to 
the oncogenesis of cells and a better 
understanding of these variables may 
one day lead to improved cancer 
treatments. One such factor is abnormal, 
over expression of certain types of 
enzymes called protein tyrosine kinases 
(PTK). A kinase may be thought of as 
a “chemical switch” since it chemically 
alters its substrates by covalently 
attaching a phosphate (PO3-2) group 
to them. Once phosphorylated, these 
substrate enzymes may be turned “on” 
or turned “off.” A specific kinase is 
FAK2 (See Figure 1.) FAK, located in the 
mammalian cell membrane, has been 
associated with several cancer types, 
including lung and breast cancer3-4 (See 
Figure 2.) A proposed substrate for FAK 
is paxillin. A substrate can be thought 
of as a key which fits a kinase lock. The 
protein paxillin is a ligand that binds to 
membrane bound receptors that trigger 
cellular transduction pathways. FAK 
functions in regulation of cell adhesion 
and that trigger cellular transduction 
pathways. FAK functions in regulation 
of cell adhesion and migration by 
phosphorylating a tyrosine residue (Y) 
in paxillin (See Figure 3.) Within the 
amino acid sequence of paxillin, there 
are many possible tyrosines, which 
can be phosphorylated by FAK (See 
Figure 4.) The aim of this project is to 
focus on the tyrosine in paxillin and 
synthesize short versions of the paxillin 
protein around this targeted residue. 
While proteins are larger (longer) 
chains of amino acids, peptides are 
short chains of 2-100 amino acids 
(See Figure 5.) The peptides for this 
research project include a specific 
Abbreviations: FAK, focal adhesion kinase; PTK, protein tyrosine kinase, ATP, adenosine triphosphate; SPPS, solid phase peptide synthesis; Fmoc, 
9-fluorenylmethoxycarbonyl; HOBt, hydroxybenzotriazole hydride; HBTU, 2-(1 H-Benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate; 
TFA, trifluroacetic acid; TIS, triisopropylsaline
94
tyrosine from the paxillin sequence, 
Y118 (Residue number 118). This was 
chosen based on previous Western 
blots using anti-paxillin antibody 
indicating that phosphorylation may 
occur at this tyrosine location.5-7 This 
study synthesized, via SPPS, tyrosine 
containing paxillin peptides.8 A general 
tyrosine peptide sequence is: 
H2N-aa7-aa6-aa5-Y-aa3-aa2-aa1-COOH.
H2N = N-terminal
COOH = C-terminal
Testing a synthesized peptide with 
the kinase FAK will provide a more 
accurate quantitative determination of 
the extent of phosphorylation instead 
of the qualitative Western blot analysis. 
This study will also investigate varying 
lengths of peptides surrounding tyrosine 
118; the range of sizes is from 12-30 
amino acids in length. Testing with FAK 
will determine if it is possible to have 12 
amino acid peptides act as a substrate 
for this kinase.
Methods
Solid Phase Peptide Synthesis (SPPS)
The peptide synthesis was automated 
with an Advanced Chemtech peptide 
synthesizer. Table 1 shows the target 
peptides for this study.
Polylysine (K) tails were attached 
to the C-terminal end of each peptide 
for adhesion to the negatively charged 
phosphocellulose paper disks used 
during assaying.9 The γ-phosphate is 
transferred to the tyrosine residue from 
ATP to produce the phosphorylated 
tyrosine YP, and ADP. This is measured 
quantitatively with γ-P32 ATP. The C-
terminal of each peptide is bonded 
to a 90µm diameter polymer resin 
bead called Wang (100-200 mesh).10 
Each amino acid attached to the 
peptide initially contains an N-α-Fmoc 
protection group and amino acids 
may also contain side chain protecting 
groups11-12 (See Figure 6 for chemical 
structures of reagents) and (See Figure 7 
for steps of SPPS.) To ensure successive 
amino acid coupling before Fmoc 
deprotection, a three-fold excess of each 
amino acid was used. The Fmoc group 
was “deprotected” or removed with 
piperidine before each coupling step. 
Activation of the amino acid’s carboxy 
group was done with HOBt and HBTU. 
A ninhydrin test was performed to 
confirm complete lysine coupling to the 
resin.13 Each peptide used 0.25 g of the 
polylysine resin. All of the other amino 
acids were attached as described above 
by the automated Advanced Chemtech 
peptide synthesizer. The continuous, 
computerized process handles larger 
peptides without compromising either 
purity or the product yield. Upon 
completion, the Wang resin and any 
amino acid side chain protecting groups 
were cleaved and deprotected by TFA 
and scavengers.14-15 Once cleaved, the 
solid peptides were obtained, rinsed, 
and dried. The amounts and percent 
yield are shown in Table 2.
Solid Phase Peptide Synthesis: Analysis and Identification of Protein Kinase Substrates
Table 1. Description of Target Peptides
Target Peptide Sequence Molecular Weight Length
Peptide #1 E114EHVY118SFPN122KKK  MW: 1249.5847 g/mol 12-mer
Peptide #2 V111GEEEHVY118SFPNKQK125KK MW: 2047.0607 g/mol 17-mer
Peptide #3 G105SPCSRVGEEEHVY118SFPNKQKSAEPSP131KKK MW: 3330.6535 g/mol 30-mer
Table 2. Analysis of Peptides
Target Peptide Grams Obtained Percent Yield
Peptide #1 0.160 76.4%
Peptide #2 0.135 39.4%
Peptide #3 02.63 47.1%
Results
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Discussion
Three peptides were successfully 
synthesized by SPPS on an automated 
peptide synthesizer. The peptides are 
in 3 successively increasing lengths 
that are identical to the structure in 
paxillin around Y118. The purpose 
is to determine, through biological 
assaying, which peptide best represents 
an actual substitution for paxillin. If 
the rates of phosphorylation on Y118 
are indistinguishable between the 
12-mer and 30-mer peptides, then 
it is reasonable to synthesize smaller 
peptides for future research. Future 
research using these peptides will be a 
confirmation of the peptide structure 
by Edman sequencing and mass 
spectrometry. Biological assaying against 
FAK, using γ-ATP32, will quantify the 
phosphorylation rate on Y118. The 
numerical results would help determine 
if Y118 is the tyrosine FAK preferably 
binds to within paxillin. 
Knowledge gained through 
research such as this would assist the 
pharmaceutical industry by providing 
a tool that could be used to screen 
thousands of possible drug molecules. 
Although these peptides are neither drugs 
nor treatments, therapeutic agents could 
be developed for FAK-related cancers. 
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Figure 1. A 3-dimensional crystal structure of FAK in ribbon structure. The peptide 
substrate is absent but ATP is shown in the center in ball & stick notation.
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Figure 2. Location of FAK within a cell and a cellular process it participates in.
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Figure 3. Cartoon representation of a tyrosine kinase phosphorylation reaction.
Figure 4. This full amino acid sequence of the paxillin protein was used to derive the 
synthesized peptides. The 30 amino acids underlined above correspond to peptide #3 in Table 1.
100 Solid Phase Peptide Synthesis: Analysis and Identification of Protein Kinase Substrates
Figure 5. A general amino acid structure is shown on the left and a dipeptide structure is shown on the 
right.  Peptides are chains of repeating units (amino acids) connected together by amide bonds (circled). 
Figure 6. Chemical structures of reagents used during peptide synthesis via SPPS. 
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Figure 7. Chemical structures of reagents used during peptide synthesis via SPPS. 
